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Abstract
Tandem repeats are found in both coding and non-coding sequences of higher organisms. These sequences can be used in
cancer genetics and diagnosis to unravel the genetic basis of tumor formation and progression. In this study, a possible
relationship between SSR distributions and lung cancer was studied by comparative analysis of EST-SSRs in normal and lung
cancerous tissues. While the EST-SSR distribution was similar between tumorous tissues, this distribution was different
between normal and tumorous tissues. Trinucleotides tandem repeats were highly different; the number of trinucleotides in
ESTs of lung cancer was 3 times higher than normal tissue. Significant negative correlation between normal and cancerous
tissue showed that cancerous tissue generates different types of trinucleotides. GGC and CGC were the more frequent
expressed trinucleotides in cancerous tissue, but these SSRs were not expressed in normal tissue. Similar to the EST level,
the expression pattern of EST-SSRs-derived amino acids was significantly different between normal and cancerous tissues.
Arg, Pro, Ser, Gly, and Lys were the most abundant amino acids in cancerous tissues, and Leu, Cys, Phe, and His were
significantly more abundant in normal tissues than in cancerous tissues. Next, the putative functions of triplet SSR-
containing genes were analyzed. In cancerous tissue, EST-SSRs produce different types of proteins. Chromodomain helicase
DNA binding proteins were one of the major protein products of EST-SSRs in the cancerous library, while these proteins
were not produced from EST-SSRs in normal tissue. For the first time, the findings of this study confirmed that EST-SSRs in
normal lung tissues are different than in unhealthy tissues, and tagged ESTs with SSRs cause remarkable differences in
amino acid and protein expression patterns in cancerous tissue. We suggest that EST-SSRs and EST-SSRs differentially
expressed in cancerous tissue may be suitable candidate markers for lung cancer diagnosis and prediction.
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Introduction
Rapid generation of genomics and functional genomics data has
providednovel,fast, and inexpensivetools infunctional dissecting of
vital phenomena like cancer identification and prediction. Ex-
pressed sequencetags (ESTs)aresequencedfrompartsofthecoding
regions of the genome under certain biological conditions [1]. ESTs
can be developed from cDNA libraries to obtain expression
information in contrasting environmental conditions or across
developmental stages to provide an inexpensive source of gene-
based DNA markers [2]. Collections of ESTs have been generated
in different human tissues, which provides a unique opportunity for
searching for SSR motifs and developing the corresponding
microsatellite markers [3]. In recent years, the increasing number
of deposited ESTs in data banks has accelerated research in this
field. A vast amount of deposited EST sequences in Harvard
University (The Gene index Project, http://compbio.dfci.harvard.
edu/tgi/tgipage.html) and NCBI) http://www.ncbi.nlm.nih.gov/
blast) provides the opportunity of precise consideration of different
biological events by EST-SSR analysis not only in DNA level but
also in amino acid and functional protein level.
The length of microsatellites or SSRs varies from one to six (or
more) units of tandem-repeated sequences. These sequences are
ubiquitously distributed in prokaryotic and eukaryotic genomes
and can be found in both the coding and non-coding sequences of
higher organisms [4,5,6,7]. In comparison with other molecular
markers, SSRs are uniquely characterized by their simplicity,
abundance, ubiquity, variation, co-dominance, and multi-alleles
nature among genomes [8]. Due to the potential of abundant
polymorphisms, SSRs have become a valuable source of genetic
markers and have been broadly applied to various areas of genetic
research, including genome variation, establishment of genetic
maps, integration of physical and genetic maps, determination of
evolutionary relationships, and comparative genome analyses
[8,9,10].
EST-SSRs, which are a combination of EST and SSRs, offer
several advantages over the other genomic DNA-based markers;
these advantages include being able to detect the variation in the
expressed portion of the genome and having a higher level of
transferability to closely related species than do genomic SSR
markers [11][12]. There is some evidence of lower EST-SSR
variation in comparison with the introns or intergenic regions, but
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are polymorphic [12]. Regarding the existence of EST-SSRs in
transcribed regions of the genome, these sequences can lead to the
development of gene-based maps for identifying functional
candidate genes and increasing the efficiency of marker-assisted
selection.
In contrast to primary assumption which suggests SSRs are not
functional elements, new studies have demonstrated that the
genomic distribution of SSRs is nonrandom, presumably because
of their effects on chromatin organization, regulation of gene
activity, recombination, DNA replication, cell cycle, and mismatch
repair) [13]. Subsets of SSRs, namely, trinucleotide repeats, are of
great interest because of their role in many human neurodegen-
erative disorders and cancers [14,15]. In fact, the expansion of
triplet repeats is responsible for the abovementioned genetic
diseases in which the rate of mutation and, consequently, disease
induction depends on the number of tandem units within the
repeat [14,15]. For example, the role of (CAG)n repeat expansions
in spinobulbar muscular atrophy and (CTG)n repeat expansions in
myotonic dystrophy are well documented [16]. Originally,
expansions were limited to trinucleotide repeats, but it is now
clear that tetrameric, pentameric and even dodecameric repeats
can also expand and lead to human disease [17]. Microsatellite
instability reflects replication errors induced by a defective
function of mismatch repair genes, resulting in appearance of
novel, non-inherited alleles in tumor cells. As a result, co-expressed
SSRs with ESTs can be correlated with clinicopathological
features of cancer, its formation, and tumor development. SSRs
have been used in cancer genetics and indirect cancer diagnosis to
help unravel the genetic basis of tumor formation and cancer
progression. Microsatellite instability has been reported in
colorectal cancer [18], breast cancer [3,19], ovarian cancer, and
other cancers [20,21,22,23,24,25,26]. However, to date, there has
been no report on the application of EST-SSRs in lung cancer.
Lung cancer is the leading cause of cancer-related deaths in
both women [27] and men [28] throughout the world; it has
surpassed breast cancer as the leading cause of cancer deaths in
women [27]. For the first time, we report differential behavior of
EST-SSRs between normal and cancerous lung tissues in DNA,
amino acid, and annotated-protein levels. At first, distribution
frequency and type of EST-SSRs were compared in normal and
cancerous lung tissues. Then, EST-derived amino acid frequencies
were compared between normal and cancerous tissues. Finally, the
putative functions of SSR-containing genes were analyzed in
normal and cancerous tissues. The result of this study can be used
for developing ESS-SSR-based detection tool for lung cancer in
future studies and opens a new avenue in investigating differential
expression of EST-SSRs as one of the possible causes of lung
cancer.
Methods
Retrieval of EST libraries
EST libraries of lung (1 from normal and 2 from cancerous
tissues) were downloaded from the EST collection (The Gene
Index Project) of Harvard University (http://compbio.dfci.
harvard.edu/tgi/tgipage.html). The EST library from normal
lung tissue (Cat No. LB36) contains 11652 ESTs. Two EST
libraries from malignant lung tumors were used: an undiffe-
rentiated large-cell carcinoma library containing 6556 ESTs (Cat
No. #5F8) and a poorly differentiated squamous-cell carcinoma
containing 6662 ESTs (Cat No. LF43).
Large cell carcinomas are a group of cancers with large,
abnormal-looking cells. These tumors usually begin along the
outer edges of the lungs. Squamous cell carcinoma, also called
epidermoid carcinoma, is the most common type of lung cancer in
men. It often begins in the bronchi, and usually does not spread as
quickly as other types of lung cancer (http://www.umm.edu/
respiratory/lungcan.htm).
Comparison of EST-SSRs between the normal and
cancerous libraries
EST-SSRs were identified by SSR Locator software as
described previously [29]. SSR Locator is a tool for detecting
and characterizing micro-and minisatellites in DNA sequences.
Beyond finding the repeating sequences, the program can also
design primers, simulate PCR reactions, and make global
alignments between homologous regions obtained from the PCR
simulation.
To evaluate the EST-SSR distribution pattern between normal
and cancerous tissues, the EST sequences of two cancerous
libraries were first pooled. Next, the EST sequences of normal and
cancerous libraries were scanned for SSR motifs ranging in length
from 2 to 6 nucleotides with dinucleotide repeat numbers $7,
trinucleotide repeat numbers $6, tetranucleotide repeat numbers
$5, pentanucleotide repeat numbers $5, and hexanucleotide
repeat numbers $5.
Comparison of EST-SSRs between cancerous libraries
Two EST libraries from cancerous tissues (Cat No. #5F8 and
Cat No. LF43) were used to test whether the EST-SSR
distribution is similar between cancerous tissues. The EST
sequences from the cancerous libraries were searched with SSR
Locator for SSRs motifs ranging from 2 to 6 nucleotides in length.
The repeat number parameters were as follows: $7 for
dinucleotides, $6 for trinucleotides, $5 for tetranucleotides, $5
for pentanucleotides, and $5 for hexanucleotides.
Primer designing for EST-SSRs
For each microsatellite-containing EST, primers were designed
using Primer3 (http://frodo.wi.mit.edu/primer3/) by running the
software in a batch mode with the assistance of the SSR locator
interface module. The primer design function was used to
determine if the sequences had sufficient flanking sequences for
designing primers. The major parameters for primer design were
as follows: PCR product size 100–300 bp, primer length 18–25 bp
with 20 bp as the optimum, optimum annealing temperature 58–
63 uC with 60 uC as the optimum, and a minimum GC content of
30%, with 50% being the optimum.
Amino acid distributions of ESTs with trinucleotide
repeats
The type of amino acids and their distributions in normal and
cancerous tissues were predicted for ESTs with trinucleotide
repeats using SSR Locator software. Translating the EST-SSRs to
their corresponding amino acids provides some clues about the
differences and similarities between normal and cancerous tissues
at the protein level.
Statistical analysis
To understand the similarities and differences between
cancerous and normal lung tissues in generation of EST-SSRs,
the Paired T-test was employed to compare the number of
expressed SSRs in each class of EST-SSRs (dinucleotides,
trinucleotides, tetranucleotides, pentanucleotides, and hexanucleo-
tides) between the normal and cancerous libraries. Different
EST-SSRs in Lung Cancer
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clusters.
In addition, to evaluate the co-linearity of cancerous and
normal tissues in generating different EST-SSRs, Pearson
correlations were calculated using MINITAB14 software (www.
minitab.com).
After predicting the amino acid composition of ESTs containing
trinucleotide tandem repeats, the number of amino acid loci and
number of amino acid repeats were compared between lung
cancerous and normal tissues by Paired T-test. Different types of
amino acids were assumed as pairing clusters.
In addition, the expressed SSRs in each class of EST-SSRs were
compared by the Paired T-test between cancerous libraries to
examine their distribution in cancerous tissues.
Annotation of SSR-containing sequences
To shed light on the putative functions of SSR-containing genes
in cancerous and normal tissues, Fasta files of all identified EST-
SSRs in cancerous and normal lung tissues were subjected to
Blast2GO (http://www.blast2go.org/) software and were run
against the non-redundant (nr) protein database of the NCBI)
http://www.ncbi.nlm.nih.gov/blast); the obtained hits were com-
piled [30]. EST-SSRs with a best e-value of 10
26 or lower were
assigned a putative identity.
Results
Frequency and distribution of EST-SSRs in normal and
cancerous tissues
In total, 24870 ESTs were analyzed by SSR locator; 13218
ESTs belonged to lung cancerous tissue, and 11652 ESTs
belonged to normal tissue (Table 1). Analyzing a large number
of ESTs in both cancerous and normal tissues provided an
opportunity to monitor precisely the behavior of the expressed
SSRs in lung cancer. The average lengths of the EST sequences in
cancerous and normal tissues were 478 and 288 bp, respectively.
This length difference clearly shows that when a lung tissue
commences to generate a tumor, a shift in alternative splicing
occurs in the whole genome, thereby producing longer ESTs and
proteins. Further studies on alternative splicing using the above-
mentioned EST libraries may unravel the splicing modulation
throughout the genome in lung cancer. As presented in Table 1, in
cancerous tissue, 238 SSRs were found on 227 ESTs sequences. In
contrast, 208 SSR were identified on 184 ESTs were found in
normal tissue (Table 1).
In normal tissue, the percentages of dinucleotides, trinucleo-
tides, tetranucleotides, pentanucleotides, and hexanucleotides
were 58.65%, 11.05%, 22.59%, 7.21%, and 0.48%, respectively
(Figure 1). In contrast, in cancerous tissues, 56.72%, 30.25%,
7.98%, 2.10%, and 2.94% of total SSRs were assigned to
dinucleotides, trinucleotides, tetranucleotides, pentanucleotides,
and hexanucleotides, respectively (Figure 1).
Based on Figure 1, the greatest difference between normal and
cancerous tissues belongs to trinucleotides. In other words,
trinucleotides are more abundant in the cancerous library than
the normal library (30.25% versus 11.05%, respectively). This
finding confirms previous results on neurodegenerative disorders
and other cancers in which triplet repeats are expanded in tumor
tissue [14,15]. According to Bacolla et al. (2008), there is a positive
correlation between the rate of defective mutations and disease
induction with an expansion of triplet repeats. Another question
still remains: is there any difference between the types of expressed
SSRs in each class of repeat units?
Comparative analysis of EST-SSR types between normal
and cancerous lung tissues
To shed light on the expressed SSR sequence modulations in
each class of repeat units during lung cancer, the frequencies of the
sequences within each class of repeat unit (dinucleotides,
trinucleotides, tetranucleotides, pentanucleotides, or hexanucleo-
tides) were compared between normal and cancerous tissues
(Figures 2, 3, 4, Supporting Information S1).
The types of dinucleotide sequences in cancerous and normal
tissue are presented in Figure 2. Five dinucleotides, AC/GT, AG/
CT, AT/TA, CA/TG, and GA/TC, were identified in both
libraries, while GC/GC was solely detected in cancerous tissue
(Figures 2, Supporting Information S1). Interestingly, the distri-
bution of dinucleotide sequences was not similar between tissues.
More than 40% of dinucleotides in the cancerous lung tissues were
AT/TA-type. In contrast, this ratio decreased to 14.75% in
normal tissue (Figures 2, Supporting Information S1). Thus, we
suggest that the AT/TA and GC/GC frequencies can be
employed to detect lung cancer.
For trinucleotides, 28 types of triplet repeats were found in
cancerous tissue, while only 19 sequence-types were detected in
normal tissue (Supporting Information S1). A differential distri-
bution of trinucleotides in normal and cancer libraries was highly
noticeable. While in normal tissue, triplet repeats were distributed
with nearly equal frequencies, the distribution of triplet repeats
was completely non-uniform in cancerous tissue. GGC and CGC
were the more frequent expressed trinucleotide repeats in
cancerous tissue (9.72% and 6.94%, respectively), while these
SSRs were not expressed in the normal tissue. In contrast, ACC,
CAC, and TTG, which were the dominant triplet tandem repeats
in normal tissue, accounted for 26% of all expressed trinucleotides
in normal tissue, rapidly disappear when the lung tissue becomes
Table 1. A summary of the ESTs and EST-SSRs distribution in cancerous and normal lung tissues.
ESTs and EST-SSRs parameters Cancer tissue Normal tissue
Total number of ESTs 13218 11652
Average length of EST sequences 478 bp 288 bp
Total number of identified SSRs 238 208
Total number of SSR-derived ESTs (Number of ESTs containing SSR) 227 184
Number and frequency of EST sequences containing one SSRs 217 (95.59%) 160 (86.95%)
Number and frequency of EST sequences containing two SSRs 9 (3.96%) 24 (13.04%)
Number and frequency of EST sequences containing three SSRs 1 (0.44%) 0 (0.00%)
doi:10.1371/journal.pone.0027118.t001
EST-SSRs in Lung Cancer
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27118Figure 1. The distribution of EST-SSRs in normal and cancerous lung tissues. The percentages of dinucleotides, trinucleotides,
tetranucleotides, pentanucleotides, and hexanucleotides have been compared between cancerous and normal tissues. Trinucleotide SSR repeats are
abundant in the ESTs of lung cancerous tissue.
doi:10.1371/journal.pone.0027118.g001
Figure 2. The distribution of different sequences of expressed dinucleotide SSRs in normal and cancerous lung tissues. AT/TA was
more frequent in cancerous tissue than in normal tissue. In addition, GC/GC was detected solely in cancerous tissue.
doi:10.1371/journal.pone.0027118.g002
EST-SSRs in Lung Cancer
PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e27118Figure 3. The distribution of different sequences of expressed trinucleotide SSRs in normal and cancerous lung tissues. A shift in
trinucleotide EST-SSRs occurs when the tissue becomes tumorigenic, with decreases being observed in ACC, CAC, and TTG triplet tandem repeats
and increases in GGC, CGC, and AGA instead.
doi:10.1371/journal.pone.0027118.g003
Figure 4. The distribution of tetranucleotide EST-SSRs in normal and cancerous lung tissues. Tetranucleotides, such as AAAC, ATCA,
TTGT, GAAG, and TAAA, were differentially expressed between normal and cancerous tissues.
doi:10.1371/journal.pone.0027118.g004
EST-SSRs in Lung Cancer
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triplet repeats can be considered as an suitable way for lung cancer
prediction and detection.
Figure 4 presents the tetranucleotide EST-SSR differences
between normal and cancerous tissues. AAAC was highly
prevalent in the normal library, whereas ATCA was highly
prevalent in cancerous tissue. However, differences in the
tetranucleotide SSR expression between cancer and normal were
not as clear as trinucleotide EST-SSRs.
Pentanucleotides and hexanucleotides EST-SSRs are shown in
Supporting Information S1. All five pentanucleotides in cancerous
tissues had similar frequencies, while ATTCC showed the highest
frequency in normal lung tissues (Supporting Information S1).
Three hexanucleotides were found in the ESTs of lung cancer,
including GCCCCA, CCTTGG, and CAACAG, while just one
hexanucleotide (ATTTTT) was detected in normal ESTs
(Supporting Information S1).
The number of EST-SSRs in each class of repeat units has been
compared between cancerous and normal tissues and is presented
in Table 2. Lung cancerous tissue statistically has a greater
number of trinucleotide tandem repeats (P=0.01). This finding
confirms the probable role of trinucleotide EST-SSRs in cancer
induction, which has been reported previously in other cancers
[14,15]. As presented in Table 2, the smaller tandem repeats
(dinucleotides and trinucleotides) were more abundant in cancer-
ous tissue than in normal tissue. In contrast, the frequencies of
tetranucleotides and pentanucleotides (larger size tandem repeats)
are higher in normal tissue.
Correlation of expressed SSRs between lung cancerous
and normal tissues
The correlation of expressed SSR sequences between normal
and cancerous tissues in each class of tandem repeats (dinucleo-
tides, trinucleotides, tetranucleotides, or pentanucleotides) is
presented in Table 3. Interestingly, a negative correlation was
found between expressions of trinucleotide-types between cancer-
ous- and normal-tissue libraries (Table 3), while correlations of
dinucleotides or tetranucleotides between normal and cancerous
libraries were positive (Table 3). In fact, in line with the alteration
of normal tissue to tumor, the expression profile of trinucleotide
EST-SSRs appears to change. Expressed trinucleotide tandem
repeats may be the best candidate for detecting and predicting
cancerous lung tissue in future studies.
Virtual PCR
In the pooled cancerous library, 156 EST-SSRs had proper
flanking regions for primer design. Consequently, 156 primers
(69% of EST-SSRs) were designed for 227 EST-SSRs in
cancerous tissues (Supporting Information S2). When virtual
PCR was run with the SSR Locator software, 81 of the primers
(52%) produced suitable fragments.
Based on proper flanking region, 113 primers were identified for
184 EST-SSRs (61% of EST-SSRs) in the normal library(Supporting
Information S3), and 93 of these primers (82% of primers) produced
SSRfragmentsduringvirtualPCR(SupportingInformationS3).The
primer sequences are presented in Supporting Information S2 and S3
and are useful in further laboratory studies on lung EST-SSRs.
Functional annotation of EST-SSRs
To explore the functions of the EST sequences containing SSRs
in both normal and cancerous tissues, BLASTX was used to
search for EST-SSRs in the non-redundant protein (nr) databank
of NCBI. A total of 117 out of 227 EST-SSRs in cancerous lung
tissue and 55 out of 187 (30%) sequences in normal lung tissues
had significant hits (Supporting Information S4 and Supporting
Information S5).
A comparative functional annotation of EST-SSRs between
normal and cancerous lung tissues is presented in Supporting
Information S6. In addition, annotated proteins for trinucletotide
EST-SSRs have been compared between normal and cancerous
lung tissues in Supporting Information S7.
Many of the annotated EST-SSRs in cancerous tissue were
related to chromodomain helicase DNA binding proteins, formin-
binding proteins, and Chromobox protein homologues, and these
genes did not express with SSRs in the normal library
(Supporting Information S6). Chromodomain helicase DNA
binding proteins solely produce from trinucletotide EST-SSRs
in cancerous tissue (Supporting Information S7). In other words,
SSRs in cancerous tissue prefer to join and target the nucleus
proteins involved in heterochromatin formation, transcriptional
activation, regulation of binding, and maintenance of hetero-
chromatin integrity.
Table 2. A comparison of the number of different EST-SSR types (dinucleotides, trinucleotides, tetranucleotides, and
pentanucleotides) between normal and lung cancerous libraries by Paired T-test.
Mean number in cancerous tissue (Mean ± SE) Mean number in normal tissue(Mean ± SE) P-Value
*
Dinucleotides 22.5068.00 20.3365.37 NS
Trinucleotides 1,9460,30 0.6260.11 P=.01
Tetranucleotides 0.1660.16 4. 0060.51 P=0.01
Pentanucleotides 0.3060.13 1.1560.27 P=0.05
Hexanucleotides 1.7560.85 0.2560.25 NS
*NS: not significant, P=0.05: significant at the 5% level, P=0.01: significant at the 1% level.
doi:10.1371/journal.pone.0027118.t002
Table 3. A comparison of the correlation between the
expressed SSR sequences in cancerous and normal lung
tissues in generating different type of SSRs in each SSR class
(the Pearson correlation test was used).
SSR class
Correlation between
Cancerous and Normal
libraries P-value
Dinucleotides +47.0% Not significant
Trinucleotides 232.4% P=0.05
Tetranucleotides +77.5% P=0.1
Pentanucleotides 246.0% Not significant
doi:10.1371/journal.pone.0027118.t003
EST-SSRs in Lung Cancer
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DNA binding proteins may result in the generation of defective
genes in lung cancer. This finding is in agreement with the results
of Li et al. (2004) regarding the effects of SSR distribution on
chromatin organization and regulation of gene activity [13].
CCAAT/enhancer-binding protein a was another interesting
target thatwasaffected by SSRs solelyin cancerous tissue; thisprotein
has a well-documented role in cell proliferation. CCAAT-enhancer-
binding proteins(orC/EBPs) are a family of transcription factorsthat
interact with the CCAAT (cytidine-cytidine-adenosine-adenosine-
thymidine) box motif, which is present in several gene promoters. C/
EBPs are characterized by a highly conserved basic-leucine zipper
(bZIP) domain at the C-terminus. This domain is involved in
dimerization and DNA binding, as are other leucine zipper
transcription factors. C/EBPs proteins are involved in different
cellular responses, such as the control of cellular proliferation, growth
and differentiation, metabolism, and immunology [31][32].
The above findings open a new avenue in lung cancer studies and
suggest that the SSRs may be both a marker for and also a cause of
cancer induction. More studies in the future are needed in this field.
Amino acid distribution of ESTs containing trinucleotide
tandem repeats
Regarding the above-mentioned results on the importance of
triplet repeats in lung cancer induction, the types of predicted
amino acids and their distributions for ESTs with trinucleotide
repeats were analyzed in normal and cancerous libraries. In
keeping with the EST (mRNA) level, the expression pattern of
EST-SSRs at the amino acid level was quite different.
The number of amino acid repeats was approximately 3 times
higher in cancerous tissue than in normal tissue (582 versus 178
repeats, respectively, p=0.01, Table 4). In addition, the type of
expressed amino acids was notably different between cancerous and
normal tissues (Table 4, Figure 5). Arg (14.60%), Pro (12.71%), Ser
(12.19%), Leu (10.19%), and Ala (8.03%) were the most abundant
amino acids in lung cancer tissues. In contrast, Leu (18.53%), Ala
(16.23%),Thr(8.42%),Gln(8.42%) werethe dominantamino acids
in normal tissue. No Thr or His was found in the EST-SSRs of
cancerous samples. On the other hand, Lys, Met, and Try were not
found in normal tissues. The result of the amino acid study of EST-
SSRs clearly shows that the induced instability of SSRs in cancerous
Table 4. A comparison of the amino acid distributions on EST-SSRs containing trinucleotide tandem repeats between cancerous
and normal tissues.
Amino acid type
Number of amino
acid loci
Number of amino
acid repeats
Percentage of different type of amino acids repeats to the
total number of repeats
Cancer Normal Cancer Normal Cancer Normal
Ala 8 1 52 29 8.93% 16.29%
Arg 14 1 85 8 14.60% 4.49%
Asn 1 1 8 6 1.37% 3.37%
Asp 4 1 24 6 4.12% 3.37%
Cys 2 2 17 14 2.92% 7.86%
Gln 7 2 41 15 7.04% 8.42%
Glu 4 1 31 6 5.32% 3.37%
Gly 7 1 50 6 8.59% 3.37%
His 0 2 0 12 0.00% 6.74%
Ile 2 1 17 5 2.92% 2.80%
Leu 7 4 64 33 10.99% 18.53%
Lys 3 0 18 0 3.09% 0.00%
Me 1 0 6 0 1.03% 0.00%
Phe 1 2 6 11 1.03% 6.17%
Pro 12 1 74 6 12.71% 3.37%
Ser 10 1 71 6 12.19% 3.37%
Thr 0 2 0 15 0.00% 8.42%
Trn 3 0 18 0 3.09% 0.00%
Tyr 0 0 0 0 0.00% 0.00%
Val 0 0 0 0 0.00% 0.00%
Total 86 23 582 178
Statistical comparison of amino acid distributions of EST-SSRs containing trinucleotide tandem repeats between cancerous and normal tissues
Cancer
* Normal
* Paired T-test
**
Number of amino acid loci 4.3060.94 1.1560.22 P=0.01
Number of amino acid repeats 29.1066.21 8.9062.02 P=0.01
*Means 6 SE.
**P=0.01: significant at the 1% level.
doi:10.1371/journal.pone.0027118.t004
EST-SSRs in Lung Cancer
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effect on the produced protein.
EST-SSR distributions within cancerous tissues
Figure 6 presents the distribution of different classes of SSRs
(dinucleotides, trinucleotides, tetranucleotides, pentanucleotides,
and hexanucleotides) on ESTs between 2 different cancerous
tissues. In addition, the different types of SSRs in each class were
compared by Paired T-test (Supporting Information S7). As shown
in Figure 6 and Supporting Information S8, there is no significant
difference between the different classes of the 2 cancerous libraries,
and EST-SSRs have similar expression patterns between cancer-
ous tissues.
Discussion
Lung cancer is the leading cause of cancer deaths in both
women [27] and men [28] throughout the world. Most lung
tumors are malignant, and only about 2% of those diagnosed with
metastatic lung cancer are alive 5 years after the diagnosis [28].
Diagnosis of lung cancer in earlier stage sharply increases the
survival rates to 49% for five years or longer.
One of the most prominent applications of molecular markers is
the detection of diseases in early stages. However, no reliable
maker has been introduced for the prediction of lung cancer.
Microsatellites are the current method of choice because SSRs can
be traced either in protein-coding or non-coding regions [33] with
high mutability and may play a significant role in genome
Figure 5. The percentages of different amino acids on ESTs containing trinucleotide tandem repeats in normal and cancerous
tissues. Figure 5 highlights the high proportion of Arg, Pro, and Ser amino acids in cancerous lung tissue.
doi:10.1371/journal.pone.0027118.g005
EST-SSRs in Lung Cancer
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the coding part of genome, serve to monitor the modulation of
microsatellites and also provide valuable information about the
effects of SSRs on disease induction and functional alteration of
genes during the disease.
In this study, we investigated SSR distribution in tumorigenic
and normal lung tissues to search for new clues at molecular level
of this cancer. To achieve this purpose, tumor libraries from lung
cancer were compared with normal lung tissue in three steps:
EST-SSR modulation, amino acid composition of translated EST-
SSRs, and functional annotation of produced EST-SSRs.
Analyzing a large number of ESTs in lung cancerous and normal
tissues (24870) provided a useful estimate of genome modulation
and alteration in lung cancer.
At the dinucleotide level, GC/GC was solely detected in
cancerous tissue. GGC and CGC were the more frequently
expressed trinucleotide repeats in cancerous tissue, while these
SSRs were not expressed in normal tissue. In fact, tumorigenic
lung ESTs were rich in GC content in comparison with normal
ESTs. This observation is in agreement with previous reports of
other cancers in human [2], animals [34], and even in plants [35].
The possible roles of GC content and repeat expansion in some
human diseases have been previously highlighted [36].
The greatest difference between normal and cancerous tissues
was observed in the expression of trinucleotides tandem repeats
within all of studied repeats. The number of trinucleotides in lung
cancer ESTs was 3 times higher than in normal ESTs (P=0.05).
In addition, the Pearson correlation test demonstrated that
cancerous tissues generate different types of trinucleotides because
negative and significant correlations (P=0.05, Table 3) were
found between cancer and normal tissues in terms of the
expression of trinucleotide types. A differential distribution of
trinucleotides in normal and cancer libraries was highly noticeable;
while triplet repeats were distributed with nearly equal frequencies
in normal tissue, the distribution of triplet repeats was non-
uniform in cancerous tissue.
In keeping with the results of the present study, microsatellite
instability has also been found in tumor samples of Turkish
patients with breast cancer [37]. Microsatellite instability may
reflect replication errors that are induced by defective mismatch
repair genes, resulting in the appearance of novel, non-inherited
alleles in tumor cells, and represents a specific pathway of tumor
development. Interestingly, this developmental pathway is corre-
lated with the clinicopathological features of breast cancer [3].
The possible structures of SSRs, particularly triplet repeats,
which are involved in human diseases have been studied
extensively [38,39,40,41,42,43]. Various repeats have shown
considerable potential to form alternative structures, such as
(CTG)n, (CAG)n, (CCG)n, (CGG)n, (GAA)n, (TTC)n, (AGG)n,
(CCT)n, (TGG)n and (CCA)s [44]. Therefore, tandem repeats may
provide valuable clues regarding human diseases and provide new
tools for disease identification, especially cancers.
The frequency of SSRs in EST-SSRs more accurately reflects
the density of SSRs in the transcribed region of the genome.
Because SSRs are inherently unstable, two models have been
proposed to explain their generation and instability: DNA
polymerase slippage (involving the transient dissociation of the
replicating DNA strands) and unequal recombination followed by
misaligned re-association. Those SSR repeats that can form
alternative DNA conformations would be expected to be
generated more frequently than others [45].
Translating the EST-SSRs to their corresponding amino acids
provided some clues about differences and similarities between
normal and cancerous tissues at the protein level. Highly
significant differences (P=0.01) were found between the type of
amino acids and their distributions in normal and cancerous
tissues (Table 4). Arg, Pro, Ser, Gly, Lys and Thr were the most
abundant amino acids in lung-cancer tissues, while the frequencies
of Leu, Cys, Phe, His and Thr were significantly higher in normal
lung tissues (Table 4). The length of the amino acid tracts encoded
by SSRs may affect the protein-protein interactions of transcrip-
tion factors [14]. Microsatellites are known to participate in both
gene and protein function [14]. These differences confirm the
Figure 6. The distribution of EST-SSRs in normal and cancerous lung tissues. The percentages of dinucleotides, trinucleotides,
tetranucleotides, pentanucleotides, and hexanucleotides have been compared between cancerous and normal tissues. EST-SSRs present similar
distribution patterns between cancerous tissues.
doi:10.1371/journal.pone.0027118.g006
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cancer.
In our previous work on breast cancer [46], we observed that
the frequency of certain structural amino acid properties, such as
Ile-Ile, can efficiently and precisely predict and discriminate
malignant from benign breast-cancer cells. In similar investiga-
tions, structural amino acid attitudes has been efficiently predicted
and modeled, including protein thermostability [47,48,49] and
halostability [50], hyperaccumulation of a protein pump [51], or
even the functional phylogeny of genes/proteins [52] using data
mining methods. Regarding the abovementioned reports, the
differential distribution of amino acids between cancerous and
normal tissues provides a new avenue in lung cancer research to
model and predict the cancer progression based on amino acid
modulation.
Analyzing EST-SSRs instead of genomic SSRs provides the
opportunity of following the behavior of a marker at the functional
and protein level. Several EST-SSRs in cancerous tissue were
related with chromodomain helicase DNA binding proteins and
formin-binding proteins, and the expression of these proteins was
not observed in normal library.
Alternative DNA conformations are one of the major causes of
repeat expansion diseases in humans [45]. With respect to the
function of Chromodomain helicase DNA binding proteins,
Chromobox protein homologues, and CCAAT/enhancer-binding
protein a in transcription, this study suggests valuable clues on
how microsatellite instability, particularly in triplet tandem
repeats, affects transcription, induces replication errors, and
generates defective genes in lung cancer.
Repeat expansion diseases are a group of human genetic
disorders caused by long and highly polymorphic tandem repeats.
While the numbers of EST-SSRs in cancerous and normal tissues
of lung were relatively similar (227 versus 184), the density of SSRs
in cancerous tissues was significantly higher, probably due to
changes in nucleotide sequences in abnormal tissues. Possible
relationships between SSRs (especially trinucleotides) and hered-
itary and genetic diseases have been reported [2,36,53,54,55].
Nearly 30 hereditary disorders in humans result from an increase
in the number of copies of simple repeats in genomic DNA. These
DNA repeats seem to be predisposed to such expansion because
they have unusual structural features that disrupt the cellular
replication, repair and recombination machineries. The presence
of expanded DNA repeats alters gene expression in human cells,
leading to disease [54].
In conclusion, while the EST-SSR distribution was uniform
between cancerous tissues, significant differences were found
between the expression pattern of SSRs (particularly trinucleo-
tides) and amino acid distributions in normal and tumorigenic
tissues. These findings confirmed that the types and distributions
of SSRs in normal tissues are different from those of unhealthy
tissues in lung cancer; therefore, EST-SSRs may be suitable
candidates for lung cancer studies. Functional analysis of EST-
SSRs at the protein level led us to chromodomain helicase DNA
binding protein and CCAAT/enhancer-binding protein a as a
possible enzyme that may interrupt DNA replication and
transcription in cancerous tissue. Based on the roles of SSRs with
more than two nucleotides in cancer and other hereditary
disorders and the significant differences found in the amino acid
distributions in normal and cancerous lung tissues in this study, a
possible relationship between SSR distributions and lung cancer
was highlighted in this study.
The results of this study clearly show that contrary to previous
assumptions, SSRs are not merely markers at the DNA level.
More importantly, SSRs intentionally target and express with
specific genes in cancer tissues. As shown in this research, the
differential expression of SSRs in cancerous tissues affects amino
acid and functional protein as well. These findings open a new
avenue for finding important defective genes/proteins that have
been tagged by SSRs, specifically in lung cancer.
Marker studies, up to now, focus mainly on marker, and little
attention has been paid to the genes which are affected by
markers. This study highlights the importance of investigating the
genes which interact with markers and suggests following the
behavior of marker-related genes in amino acid and protein level.
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